| P50 | author | A. Sue Menko | Q67269561 |
| P2093 | author name string | Y Qian | |
| | E J Van Bockstaele | |
| | M E Page | |
| | V C Oropeza | |
| | S E Sparks | |
| P2860 | cites work | Acute administration of the CB1 cannabinoid receptor antagonist SR 141716A induces anxiety-like responses in the rat. | Q51106735 |
| | Corticotropin-releasing factor (CRF) antagonist [D-Phe12,Nle21,38,C alpha MeLeu37]CRF attenuates the acute actions of the highly potent cannabinoid receptor agonist HU-210 on defensive-withdrawal behavior in rats. | Q51119047 |
| | Heavy cannabis users seeking treatment- prevalence of psychiatric disorders. | Q51942095 |
| | Tyrosine hydroxylase allelic distribution in suicide attempters | Q57844228 |
| | Role of ion flux in the control of c-fos expression | Q57963317 |
| | Effects of acute restraint stress on tyrosine hydroxylase mRNA expression in locus coeruleus of Wistar and Wistar-Kyoto rats | Q73387819 |
| | AP1 proteins mediate the cAMP response of the dopamine beta-hydroxylase gene | Q77195545 |
| | Cannabinoid CB(1) receptors colocalize with tyrosine hydroxylase in cultured fetal mesencephalic neurons and their activation increases the levels of this enzyme | Q28372132 |
| | Modulation of anxiety through blockade of anandamide hydrolysis | Q29615902 |
| | Role of locus coeruleus in attention and behavioral flexibility | Q33772717 |
| | Cellular and synaptic adaptations mediating opioid dependence. | Q34127771 |
| | Administration of marijuana to heavy and casual marijuana users | Q34223948 |
| | Action of cannabidiol on the anxiety and other effects produced by delta 9-THC in normal subjects | Q34253509 |
| | Measuring normal and pathological anxiety-like behaviour in mice: a review. | Q34420641 |
| | Cocaine dependence: a disease of the brain's reward centers | Q34453329 |
| | The relationship between cannabis use, depression and anxiety among Australian adults: findings from the National Survey of Mental Health and Well-Being. | Q34517152 |
| | Adverse effects of cannabis on health: an update of the literature since 1996. | Q34550790 |
| | Behavioral neurobiology of alcohol addiction: recent advances and challenges. | Q34616149 |
| | Study of cannabinoid dependence in animals | Q34786835 |
| | Marijuana withdrawal syndrome in the animal model | Q34986723 |
| | Neural substrates of opiate withdrawal | Q35324827 |
| | Antidepressants and brain monoaminergic systems: a dimensional approach to understanding their behavioural effects in depression and anxiety disorders | Q35683247 |
| | Role of endocannabinoid system in mental diseases | Q35869726 |
| | Discharge of noradrenergic locus coeruleus neurons in behaving rats and monkeys suggests a role in vigilance | Q37042696 |
| | Biogenic amines and the states of sleep | Q39890680 |
| | Nucleus locus ceruleus: new evidence of anatomical and physiological specificity | Q40136364 |
| | Use of the elevated plus maze in the search for novel anxiolytic agents | Q40532095 |
| | The role of noradrenaline in depression: a review | Q40909761 |
| | The prenatal exposure to delta 9-tetrahydrocannabinol affects the gene expression and the activity of tyrosine hydroxylase during early brain development. | Q42279605 |
| | Acute methamphetamine administration increases tyrosine hydroxylase mRNA levels in the rat locus coeruleus | Q42450241 |
| | Possible role of the cytochrome P450-linked monooxygenase system in preventing delta 9-tetrahydrocannabinol-induced stimulation of tuberoinfundibular dopaminergic activity in female rats | Q42492428 |
| | Effects of acute and chronic reboxetine treatment on stress-induced monoamine efflux in the rat frontal cortex | Q42523098 |
| | Effects of perinatal exposure to delta 9-tetrahydrocannabinol on the fetal and early postnatal development of tyrosine hydroxylase-containing neurons in rat brain | Q42528193 |
| | Behavioral and molecular changes elicited by acute administration of SR141716 to Delta9-tetrahydrocannabinol-tolerant rats: an experimental model of cannabinoid abstinence | Q42625437 |
| | Spontaneous and precipitated withdrawal with a synthetic cannabinoid, WIN 55212-2. | Q43562046 |
| | Psychiatric symptoms in male cannabis users not using other illicit drugs | Q43749493 |
| | The distribution of cannabinoid-induced Fos expression in rat brain: differences between the Lewis and Wistar strain. | Q43807460 |
| | Involvement of the opioid system in the anxiolytic-like effects induced by Delta(9)-tetrahydrocannabinol | Q44107486 |
| | Blockade of the mGlu5 receptor decreases basal and stress-induced cortical norepinephrine in rodents | Q45270570 |
| | Systemic administration of WIN 55,212-2 increases norepinephrine release in the rat frontal cortex | Q46520239 |
| | Regulation of tyrosine hydroxylase promoter activity by chronic morphine in TH9.0-LacZ transgenic mice. | Q48346547 |
| | A.E. Bennett Research Award. Anatomic basis for differential regulation of the rostrolateral peri-locus coeruleus region by limbic afferents | Q48375615 |
| | Emotional response to intravenous delta9tetrahydrocannabinol during oral surgery | Q48394577 |
| | Identification of cell type-specific promoter elements associated with the rat tyrosine hydroxylase gene using transgenic founder analysis | Q48581183 |
| | Opiate modulation of striatal dopamine and hippocampal norepinephrine release following morphine withdrawal | Q48793103 |
| | Identification of MARPP-58, a morphine- and cyclic AMP-regulated phosphoprotein of 58 kDa, as tyrosine hydroxylase: evidence for regulation of its expression by chronic morphine in the rat locus coeruleus | Q48930201 |
| | Norepinephrine-containing locus coeruleus neurons in behaving rats exhibit pronounced responses to non-noxious environmental stimuli. | Q49162607 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cannabinoids | Q422936 |
| P304 | page(s) | 162-168 | |
| P577 | publication date | 2007-01-09 | |
| P1433 | published in | Pharmacology, Biochemistry and Behavior | Q15716554 |
| P1476 | title | Repeated cannabinoid administration increases indices of noradrenergic activity in rats | |
| P478 | volume | 86 | |